Jeremy Grantham Dr Reddys Laboratories LTD Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $30.8 Billion
- Q1 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 558,135 shares of RDY stock, worth $8.19 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
558,135
Previous 359,235
55.37%
Holding current value
$8.19 Million
Previous $5.67 Million
29.78%
% of portfolio
0.02%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding RDY
# of Institutions
266Shares Held
100MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.12.2MShares$178 Million0.3% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$135 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$133 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$128 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$91 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.44B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...